Verrica Pharmaceuticals Inc. Research And Development Expense

• Verrica Pharmaceuticals Inc. showed a decrease of -25.2% in Research And Development Expense from 2024 to 2025.
• This data is from Verrica Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
• XBRL data for this metric is available from 2017 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2017 to 2025), Verrica Pharmaceuticals Inc.'s Research And Development Expense has grown by 137.4%.
• Historical annual values: Fiscal year 2025: $8.86 million | Fiscal year 2024: $11.84 million | Fiscal year 2023: $20.30 million | Fiscal year 2023: $4.50 million | Fiscal year 2022: $12.20 million | Fiscal year 2021: $15.93 million | Fiscal year 2020: $15.67 million | Fiscal year 2019: $15.44 million | Fiscal year 2018: $12.83 million | Fiscal year 2017: $3.73 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026